Scholtz & Company, LLC Medpace Holdings, Inc. Transaction History
Scholtz & Company, LLC
- $234 Million
- Q2 2024
A detailed history of Scholtz & Company, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Scholtz & Company, LLC holds 1,671 shares of MEDP stock, worth $572,985. This represents 0.29% of its overall portfolio holdings.
Number of Shares
1,671
Previous 1,600
4.44%
Holding current value
$572,985
Previous $646,000
6.5%
% of portfolio
0.29%
Previous 0.29%
Shares
2 transactions
Others Institutions Holding MEDP
# of Institutions
652Shares Held
25.6MCall Options Held
38.7KPut Options Held
79.5K-
Black Rock Inc. New York, NY2.58MShares$884 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$867 Million0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT967KShares$332 Million2.15% of portfolio
-
Invesco Ltd. Atlanta, GA807KShares$277 Million0.07% of portfolio
-
State Street Corp Boston, MA703KShares$241 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $10.7B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...